Cuadernos Hospital de Clínicas
versão impressa ISSN 1562-6776
Resumo
FRANZ, Calani-Lazcano et al. COVID-19 mortality and comorbidity, La Paz - Bolivia, 2020 - 2022. Cuad. - Hosp. Clín. [online]. 2024, vol.65, n.1, pp.26-32. ISSN 1562-6776. https://doi.org/10.53287/xats3310ys90f.
OBJECTIVE:
To describe the characteristics of COVID-19 mortality and comorbidity in La Paz city, Bolivia, during the years 2020 - 2022.
MATERIAL AND METHODS:
Since March 2020 to February 2022, a two-year period, we studied data from the Vital Events Administration System (SIAVH) of the National Health Information System - Epidemiological Surveillance (SNIS-VE) of the Ministry of Health. The study included 700 cases: 564 (80.5%) in 2020, 112 (16%) in 2021, and 24 (3.4%) in 2022. Among these, 520 (74.3%) of them were diagnosed as positive through laboratory testing, while the remainder had clinically diagnosis.
RESULTS:
Male mortality was 69.7%, while female mortality was 30.3%, with a predominance among the elderly population. A total of 5956.5 Years of Potential Life Lost (YPLL) were recorded. The study presents sociodemographic characteristics of the affected population, epidemiological trends by week, age, and sex-specific mortality rates, and comorbidities.
CONCLUSIONS:
This study shows the experience lived in La Paz due to COVID-19 caused by the SARS-CoV-2 virus. Similar findings have been observed in regional studies, where male sex and the elderly population have predominated. Diabetes and hypertension have emerged as the most significant comorbidities.
Palavras-chave : Mortality; COVID-19; comorbidity; high altitude.











uBio 
